RecallDepth
Class III Terminated

Paroxetine Extended-Release Tablets USP, 12.5 mg, 30 count bottle, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland, 21202, Manufactured by: Lupin Limited, Pithampur (M.P.) 454 775, India, NDC: 68180-647-06

This recall has been terminated (originally issued July 19, 2017).

Company
Lupin Pharmaceuticals Inc.
Recall Initiated
June 22, 2017
Posted
July 19, 2017
Recall Number
D-0974-2017
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
12480 bottles
Firm Location
Baltimore, MD, United States
Official Source
View on FDA website ↗

Reason for Recall

Failed Dissolution Specifications: out of specification observed in dissolution testing at 3 month long term stability study.

Distribution

Nationwide in the USA

Lot / Code Info

Lots: H605712, H605711, H605710, EXP November 2018; H702255, H702202 EXP March 2019

More recalls by Lupin Pharmaceuticals Inc.

View all recalls by this company →

Other recent Class III Drug recalls